Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Curvietto M"" wg kryterium: Autor


Tytuł:
Epigenetic Regulation in Melanoma: Facts and Hopes.
Autorzy:
Giunta EF; Oncology Unit, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, 80131 Naples, Italy.
Arrichiello G; Oncology Unit, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, 80131 Naples, Italy.
Curvietto M; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, 80144 Naples, Italy.
Pappalardo A; Oncology Unit, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, 80131 Naples, Italy.
Bosso D; Oncology Unit, Ospedale del Mare, 80147 Naples, Italy.
Rosanova M; Oncology Unit, Ospedale del Mare, 80147 Naples, Italy.
Diana A; Oncology Unit, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, 80131 Naples, Italy.; Oncology Unit, Ospedale del Mare, 80147 Naples, Italy.
Giordano P; Oncology Unit, Ospedale del Mare, 80147 Naples, Italy.
Petrillo A; Oncology Unit, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, 80131 Naples, Italy.; Oncology Unit, Ospedale del Mare, 80147 Naples, Italy.
Federico P; Oncology Unit, Ospedale del Mare, 80147 Naples, Italy.
Fabozzi T; Oncology Unit, Ospedale del Mare, 80147 Naples, Italy.
Parola S; Oncology Unit, Department of Clinical Medicine and Surgery, Università degli Studi di Napoli Federico II, 80131 Naples, Italy.
Riccio V; Oncology Unit, Department of Clinical Medicine and Surgery, Università degli Studi di Napoli Federico II, 80131 Naples, Italy.
Mucci B; Oncology Unit, Department of Clinical Medicine and Surgery, Università degli Studi di Napoli Federico II, 80131 Naples, Italy.
Vanella V; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, 80144 Naples, Italy.
Festino L; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, 80144 Naples, Italy.
Daniele B; Oncology Unit, Ospedale del Mare, 80147 Naples, Italy.
Ascierto PA; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, 80144 Naples, Italy.
Ottaviano M; Oncology Unit, Ospedale del Mare, 80147 Naples, Italy.; CRCTR Coordinating Rare Tumors Reference Center of Campania Region, 80131 Naples, Italy.
On Behalf Of Scito Youth
Pokaż więcej
Źródło:
Cells [Cells] 2021 Aug 11; Vol. 10 (8). Date of Electronic Publication: 2021 Aug 11.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Epigenesis, Genetic*/drug effects
Melanoma/*genetics
Skin Neoplasms/*genetics
Antineoplastic Agents/therapeutic use ; Chromatin Assembly and Disassembly ; DNA Methylation ; Drug Resistance, Neoplasm/drug effects ; Drug Resistance, Neoplasm/genetics ; Humans ; Melanoma/pathology ; Melanoma/therapy ; RNA, Untranslated/genetics ; RNA, Untranslated/metabolism ; Skin Neoplasms/pathology ; Skin Neoplasms/therapy
Czasopismo naukowe
Tytuł:
Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology.
Autorzy:
Pascarella G; Scientific Directorate, Istituto Nazionale Tumori 'Fondazione G. Pascale', IRCCS, Napoli, Italy.
Capasso A; Dipartimento di Diritto, Economia, Management e Metodi Quantitativi, Università degli Studi del Sannio, Benevento, Italy.
Nardone A; Dipartimento Sanità Pubblica, Università Federico II, Napoli, Italy.
Triassi M; Dipartimento Sanità Pubblica, Università Federico II, Napoli, Italy.
Pignata S; Dipartimento di Oncologia Uro-Ginecologica, Istituto Nazionale Tumori, 'Fondazione G.Pascale', IRCCS, Napoli, Italy.
Arenare L; Dipartimento di Oncologia Uro-Ginecologica, Istituto Nazionale Tumori, 'Fondazione G.Pascale', IRCCS, Napoli, Italy.
Ascierto P; Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori,'Fondazione G.Pascale', IRCCS, Napoli, Italy.
Curvietto M; Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori,'Fondazione G.Pascale', IRCCS, Napoli, Italy.
Maiolino P; Hospital Pharmacy, Istituto Nazionale Tumori, 'Fondazione G.Pascale', IRCCS, Napoli, Italy.
D'Aniello R; Hospital Pharmacy, Istituto Nazionale Tumori, 'Fondazione G.Pascale', IRCCS, Napoli, Italy.
Montanino A; Thoracic Medical Oncology, Istituto Nazionale Tumori, 'Fondazione G.Pascale', IRCCS, Napoli, Italy.
Laudato F; Thoracic Medical Oncology, Istituto Nazionale Tumori, 'Fondazione G.Pascale', IRCCS, Napoli, Italy.
De Feo G; Scientific Directorate, Istituto Nazionale Tumori 'Fondazione G. Pascale', IRCCS, Napoli, Italy.
Botti G; Scientific Directorate, Istituto Nazionale Tumori 'Fondazione G. Pascale', IRCCS, Napoli, Italy.
Perrone F; Clinical Trials Unit, Istituto Nazionale Tumori, 'Fondazione G.Pascale', IRCCS, Napoli, Italy.
Petrillo A; Radiology Unit, Istituto Nazionale Tumori, 'Fondazione G.Pascale', IRCCS, Napoli, Italy.
Cavalcanti E; Laboratory Medicine Unit, Istituto Nazionale Tumori, 'Fondazione G.Pascale', IRCCS, Napoli, Italy.
Lastoria S; Nuclear Medicine Unit, Istituto Nazionale Tumori, 'Fondazione G.Pascale', IRCCS, Napoli, Italy.
Maurea N; Division of Cardiology, Istituto Nazionale Tumori, 'Fondazione G.Pascale', IRCCS, Napoli, Italy.
Morabito A; Thoracic Medical Oncology, Istituto Nazionale Tumori, 'Fondazione G.Pascale', IRCCS, Napoli, Italy.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Jan 08; Vol. 14 (1), pp. e0210330. Date of Electronic Publication: 2019 Jan 08 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Health Care Costs*
Antineoplastic Agents/*economics
Antineoplastic Agents/*therapeutic use
Neoplasms/*drug therapy
Neoplasms/*economics
Randomized Controlled Trials as Topic/*economics
Antineoplastic Agents, Immunological/economics ; Antineoplastic Agents, Immunological/therapeutic use ; Clinical Trials, Phase III as Topic/economics ; Drug Costs ; Female ; Humans ; Italy ; Male ; Multicenter Studies as Topic/economics
Czasopismo naukowe
Tytuł:
EP-1392: The abscopal effect:efficacy of radiotherapy in patients on progression after ipilimumab 3 mg/kg.
Autorzy:
Grimaldi, A.M.
Ascierto, P.A.
Simeone, E.
Giannarelli, D.
Falivene, S.
Borzillo, V.
Giugliano, F.
Sandomenico, F.
Petrillo, A.
Curvietto, M.
Esposito, A.
Paone, M.
Palla, M.
Palmieri, G.
Caraco, C.
Ciliberto, G.
Mozzillo, N.
Muto, P.
Pokaż więcej
Źródło:
Radiotherapy & Oncology. Apr2016 Supplement 1, Vol. 119, pS649-S650. 1p.
Czasopismo naukowe
Tytuł:
Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy.
Autorzy:
Mozzillo N; Melanoma and Sarcoma Surgery Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale' ; Naples, Italy.
Simeone E; Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale' ; Naples, Italy.
Benedetto L; Melanoma and Sarcoma Surgery Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale' ; Naples, Italy.
Curvietto M; Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale' ; Naples, Italy.
Giannarelli D; Statistical Unit; Regina Elena National Cancer Institute ; Rome, Italy.
Gentilcore G; Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale' ; Naples, Italy.
Camerlingo R; Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale' ; Naples, Italy.
Capone M; Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale' ; Naples, Italy.
Madonna G; Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale' ; Naples, Italy.
Festino L; Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale' ; Naples, Italy.
Caracò C; Melanoma and Sarcoma Surgery Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale' ; Naples, Italy.
Di Monta G; Melanoma and Sarcoma Surgery Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale' ; Naples, Italy.
Marone U; Melanoma and Sarcoma Surgery Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale' ; Naples, Italy.
Di Marzo M; Melanoma and Sarcoma Surgery Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale' ; Naples, Italy.
Grimaldi AM; Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale' ; Naples, Italy.
Mori S; Melanoma and Sarcoma Surgery Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale' ; Naples, Italy.
Ciliberto G; Scientific Direction; Istituto Nazionale Tumori Fondazione 'G. Pascale' ; Naples, Italy.
Ascierto PA; Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale' ; Naples, Italy.
Pokaż więcej
Źródło:
Oncoimmunology [Oncoimmunology] 2015 May 22; Vol. 4 (6), pp. e1008842. Date of Electronic Publication: 2015 May 22 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł:
Serious haematological toxicity during and after ipilimumab treatment: a case series.
Autorzy:
Simeone E
Grimaldi AM
Esposito A
Curvietto M
Palla M
Paone M
Mozzillo N
Ascierto PA; Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori Fondazione 'G, Pascale', Via Mariano Semmola, 80131 Napoli, Italy. .
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2014 Jul 01; Vol. 8, pp. 240. Date of Electronic Publication: 2014 Jul 01.
Typ publikacji:
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anemia/*chemically induced
Antibodies, Monoclonal/*adverse effects
Neutropenia/*chemically induced
Aged ; Female ; Humans ; Ipilimumab ; Male ; Middle Aged ; Neoplasms/drug therapy ; Severity of Illness Index
Czasopismo naukowe
Tytuł:
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy.
Autorzy:
Grimaldi AM; Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale'; Naples, Italy.
Simeone E; Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale'; Naples, Italy.
Giannarelli D; Statistical Unit; Regina Elena National Cancer Institute; Rome, Italy.
Muto P; Radiotherapy Unit, Istituto Nazionale Tumori Fondazione 'G. Pascale'; Naples, Italy.
Falivene S; Radiotherapy Unit, Istituto Nazionale Tumori Fondazione 'G. Pascale'; Naples, Italy.
Borzillo V; Radiotherapy Unit, Istituto Nazionale Tumori Fondazione 'G. Pascale'; Naples, Italy.
Giugliano FM; Radiotherapy Unit, Istituto Nazionale Tumori Fondazione 'G. Pascale'; Naples, Italy.
Sandomenico F; Radiology Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale'; Naples, Italy.
Petrillo A; Radiology Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale'; Naples, Italy.
Curvietto M; Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale'; Naples, Italy.
Esposito A; Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale'; Naples, Italy.
Paone M; Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale'; Naples, Italy.
Palla M; Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale'; Naples, Italy.
Palmieri G; National Research Council; Sassari, Italy.
Caracò C; Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale'; Naples, Italy.
Ciliberto G; Scientific Direction; Istituto Nazionale Tumori Fondazione 'G. Pascale'; Naples, Italy.
Mozzillo N; Melanoma and Sarcoma Surgery Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale'; Naples, Italy.
Ascierto PA; Melanoma, Cancer Immunotherapy, and Innovative Therapy Unit; Istituto Nazionale Tumori Fondazione 'G. Pascale'; Naples, Italy.
Pokaż więcej
Źródło:
Oncoimmunology [Oncoimmunology] 2014 May 14; Vol. 3, pp. e28780. Date of Electronic Publication: 2014 May 14 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies